Coastal Infusion Administers Bimzelx®
| J-Code | Not yet assigned |
|---|---|
| Manufacturer | UCB |
| First Approved | 10/18/2023 |
Coastal Infusion can administer your Bimzelx prescription at any of our south Florida locations.
Bimzelx (bimekizumab) is indicated for the treatment of moderate to severe plaque psoriasis.
The active substance in Bimzelx, bimekizumab, is a monoclonal antibody, that targets interleukin-17A (IL-17A) and IL-17F. High levels of these interleukins are involved in developing inflammatory diseases caused by the immune system.
By attaching to these interleukins, bimekizumab prevents them from interacting with their receptors within the body, which reduces inflammation and improves the symptoms related to these diseases.
What It Treats
- Plaque psoriasis
- Psoriatic arthritis
- Axial spondylarthritis
Prescribed By
Bimzelx is most often prescribed by Rheumatologists and Dermatologists.
How it’s Administered
Bimzelx is administered by subcutaneous injection. Bimzelx injections take only a few minutes.
Frequency
Bimzelx injections are given every four weeks until week 16, then every two months.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies